Lina is an international scientific collaborator that has been involved in the creation of more than a dozen life sciences status and has worked closely with hundreds of researchers worldwide to evaluate, assess and develop promising technologies and discoveries. Lina‘s main area of expertise is in translational medicine (from bench to bed), and early stage company formation (from academia to startup). Lina‘s professional experience ranges from drug discovery & development (Novartis), identification of promising innovation from academia (Novartis and Brigham and Women’s Hospital), to creation of new companies and early startup growth phase (Brigham and Women’s Hospital, Emulate/Harvard Medical School). That, combined with her personal experience as a patient with a rare disease, led her to the formation of TMA Precision Health – a team of several prominent world-leading scientists, entrepreneurs and healthcare experts put together to radically improve the care of patients with rare and undiagnosed diseases. She is renowned for her ability to quickly assess and develop compelling strategic roadmaps for promising technologies and discoveries with realistic potential to produce therapeutic breakthroughs for patients, employing a powerful network of research relationships and collaborative partnerships around the globe. Lina holes a DVM PhD from the University of Bern in Switzerland.